Literature DB >> 9048857

Uric acid-related nephrolithiasis.

R K Low1, M L Stoller.   

Abstract

Abnormalities in uric acid metabolism are associated with uric acid and calcium oxalate urolithiasis. Clinical stone formation depends on multiple identifiable risk factors that affect uric acid and calcium oxalate solubility. The understanding of urinary pH is critical to direct appropriate treatment of uric acid-related nephrolithiasis. Understanding uric acid metabolism and the pathophysiology of uric acid and calcium oxalate stone formation leads to a rational treatment approach to uric acid and hyperuricosuric calcium oxalate stone disease.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9048857     DOI： 10.1016/s0094-0143(05)70359-1

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  12 in total

Review 1.  Nephrology: 1. Investigation and treatment of recurrent kidney stones.

Authors:  A Ross Morton; Eduard A Iliescu; James W L Wilson
Journal:  CMAJ       Date:  2002-01-22       Impact factor: 8.262

2.  Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi.

Authors:  Osama El-Gamal; Mohamed El-Bendary; Maged Ragab; Mohamed Rasheed
Journal:  Urol Res       Date:  2011-08-21

3.  Inhibition of calcium oxalate crystal deposition on kidneys of urolithiatic rats by Hibiscus sabdariffa L. extract.

Authors:  Reena Laikangbam; M Damayanti Devi
Journal:  Urol Res       Date:  2011-11-05

4.  Melamine-induced infant urinary calculi: a report on 24 cases and a 1-year follow-up.

Authors:  Xiangbo Zhang; Jinliang Bai; Pengcheng Ma; Jianhua Ma; Jianghou Wan; Bin Jiang
Journal:  Urol Res       Date:  2010-06-02

5.  Evalution of antiurolithic activity of alcoholic extract of roots of cissampelos pareira in albino rats.

Authors:  Suresh Babu Sayana; Chitra C Khanwelkar; Venkat Rao Nimmagadda; Vasant R Chavan; Ramesh Bh; Naveen Kumar S
Journal:  J Clin Diagn Res       Date:  2014-06-05

6.  Uric Acid nephrolithiasis: recent progress and future directions.

Authors:  Tin C Ngo; Dean G Assimos
Journal:  Rev Urol       Date:  2007

7.  Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Petter Bjornstad; Mark H H Kramer; Michaela Diamant; Ewout J Hoorn; Jaap A Joles; Daniël H van Raalte
Journal:  Diabetes Obes Metab       Date:  2018-02-20       Impact factor: 6.577

8.  Dissolution of uric acid stones causing acute obstructing anuria in three consecutive infants.

Authors:  Mete Kaya; Mustafa Soran; Mehmet Emin Boleken; Mehmet Erdal Memedoglu; Selçuk Yücesan
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 9.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546

10.  Antiurolithiatic and antioxidant activity of Hordeum vulgare seeds on ethylene glycol-induced urolithiasis in rats.

Authors:  Jignesh G Shah; Bharat G Patel; Sandip B Patel; Ravindra K Patel
Journal:  Indian J Pharmacol       Date:  2012 Nov-Dec       Impact factor: 1.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.